Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$60.26
-7.22-10.70%
At close: -
$60.25
-0.01000-0.02%
After Hours: 4:56 PM EDT
Comments
Loading...
Biomarin Pharmaceutical Stock Price, Quotes and Forecasts
BMRNNASDAQ
Biomarin Pharmaceutical (BMRN) Forecast
NewsEarningsBiomarin Pharmaceutical (BMRN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Biomarin Pharmaceutical Stock Price, Quotes and Forecasts | NASDAQ:BMRN | Benzinga
Explore Biomarin Pharmaceutical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BMRN.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Biomarin Pharmaceutical (BMRN) stock?
You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Who are Biomarin Pharmaceutical (BMRN) competitors?
Other companies in Biomarin Pharmaceutical’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Biomarin Pharmaceutical (BMRN) stock?
Biomarin Pharmaceutical has a consensus price target of $97.50.
What is the current price for Biomarin Pharmaceutical (BMRN)?
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $60.25 last updated April 4, 2025 at 4:56 PM EDT.
Does Biomarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for Biomarin Pharmaceutical.
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical’s Q1 earnings are confirmed for Wednesday, April 23, 2025.
Is Biomarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for Biomarin Pharmaceutical.
What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.